Insider Selling: Amicus Therapeutics, Inc. (NASDAQ:FOLD) Insider Sells $19,376.00 in Stock

Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) insider David Michael Clark sold 1,384 shares of Amicus Therapeutics stock in a transaction dated Tuesday, January 9th. The shares were sold at an average price of $14.00, for a total value of $19,376.00. Following the completion of the sale, the insider now owns 266,705 shares of […]

Related Keywords

United States ,China ,America ,David Michael Clark ,Skyview Investment Advisors ,Jpmorgan Chase Co ,Nasdaq ,China Universal Asset Management Co ,Amicus Therapeutics ,Exchange Traded Concepts ,Morgan Stanley ,Amicus Therapeutics Inc ,Get Free Report ,View Investment Advisors ,Traded Concepts ,China Universal Asset Management ,Universal Asset Management ,Amicus Therapeutics Daily ,Nasdaq Fold ,Fold ,Medical ,03152w10 ,Insider Trading ,Nsider Trades ,Stocks ,